TCL Archive Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy May 30, 2014
TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001